QCT Standardization in Cystic Fibrosis
Cystic Fibrosis (CF)
Development/ValidationActive
Key Facts
About Thirona
Thirona is a leader in AI-driven lung image analysis, leveraging over two decades of research to transform subjective CT scan interpretation into objective, quantitative data. Its core LungQ platform is extensively validated and used globally by hospitals and pharmaceutical companies to characterize complex respiratory diseases like COPD, severe asthma, and cystic fibrosis. The company operates a B2B platform and services model, generating revenue by accelerating clinical trials and enabling precision pulmonary interventions.
View full company profileTherapeutic Areas
Other Cystic Fibrosis (CF) Drugs
| Drug | Company | Phase |
|---|---|---|
| CFTR Program (via Boehringer Ingelheim) | AlveoGene | Phase 1 |
| KB407 | Krystal Biotech | Phase 1 |